Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatments in an outpatient transplant clinic.

被引:0
|
作者
Smallwood, GA
Davis, L
Martinez, E
Stieber, AC
Heffron, TG
机构
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] Emory Univ Hosp Pharm, Atlanta, GA USA
来源
PHARMACOTHERAPY | 2003年 / 23卷 / 10期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1365 / 1366
页数:2
相关论文
共 50 条
  • [1] Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatment
    Smallwood, GA
    Devine, R
    Lehneman, J
    Connor, K
    Stieber, AC
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 500 - 500
  • [2] Preemptive therapy with combination of interferon and ribavirin in liver transplant recipients with hepatitis C
    Dono, Keizo
    Marubashi, Shigeru
    Kobayashi, Shogo
    Nagano, Hiroaki
    Monden, Morito
    TRANSPLANT INTERNATIONAL, 2007, 20 : 290 - 290
  • [3] Interferon alfa and ribavirin for orthotopic liver transplant recipients with recurrent hepatitis C.
    Firpi, RJ
    Abdelmalek, MF
    Lauwers, GY
    Nelson, DR
    GASTROENTEROLOGY, 2000, 118 (04) : A1018 - A1018
  • [4] Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C
    Abdelmalek, MF
    Firpi, RJ
    Soldevila-Pico, C
    Reed, AI
    Hemming, AW
    Liu, C
    Crawford, JM
    Davis, GL
    Nelson, DR
    LIVER TRANSPLANTATION, 2004, 10 (02) : 199 - 207
  • [5] Ribavirin monotherapy in liver transplant recipients with recurrent hepatitis C
    Lionetti, R
    Tisone, G
    Di Paolo, D
    Zazza, S
    Casarelli, F
    Manzia, TM
    Petrolati, A
    Cepparalo, M
    Angelico, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 39 - 40
  • [6] Preemptive therapy with combination pegylated interferon and ribavirin in liver transplant recipients with hepatitis C virus
    Neff, GW
    O'Brien, CB
    Safdar, K
    Ruiz, P
    Bejarano, P
    Montalbano, M
    Schiff, ER
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [7] Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection
    Roche, B
    Roque-Afonso, AM
    Sebagh, M
    Feray, C
    Guettier, C
    Dussaix, E
    Castaing, D
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2003, 38 : 48 - 49
  • [8] A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C
    Shakil, AO
    McGuire, B
    Crippin, J
    Teperman, L
    Demetris, AJ
    Conjeevaram, H
    Gish, R
    Kwo, P
    Balan, V
    Wright, TL
    Brass, C
    Rakela, J
    HEPATOLOGY, 2002, 36 (05) : 1253 - 1258
  • [9] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [10] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    HEPATOLOGY, 2002, 36 (04) : 182A - 182A